BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30170071)

  • 1. Protein phosphatase 2A as therapeutic targets in various disease models.
    Baskaran R; Velmurugan BK
    Life Sci; 2018 Oct; 210():40-46. PubMed ID: 30170071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.
    Janssens V; Goris J
    Biochem J; 2001 Feb; 353(Pt 3):417-39. PubMed ID: 11171037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.
    Nematullah M; Hoda MN; Khan F
    Mol Neurobiol; 2018 Feb; 55(2):1750-1761. PubMed ID: 28224476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration.
    Clark AR; Ohlmeyer M
    Pharmacol Ther; 2019 Sep; 201():181-201. PubMed ID: 31158394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles and regulation of protein phosphatase 2A (PP2A) in the heart.
    Lubbers ER; Mohler PJ
    J Mol Cell Cardiol; 2016 Dec; 101():127-133. PubMed ID: 27832939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphatase 2A: who shall regulate the regulator?
    Goldberg Y
    Biochem Pharmacol; 1999 Feb; 57(4):321-8. PubMed ID: 9933020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein phosphatase 2A: its structure, function and activity regulation].
    Liu WJ; Shen Y; Ding J
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):105-12. PubMed ID: 12545214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 2A: the Trojan Horse of cellular signaling.
    Sontag E
    Cell Signal; 2001 Jan; 13(1):7-16. PubMed ID: 11257442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences.
    Kowluru A; Matti A
    Biochem Pharmacol; 2012 Sep; 84(5):591-7. PubMed ID: 22583922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
    Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
    FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease.
    Theendakara V; Bredesen DE; Rao RV
    Mol Cell Neurosci; 2017 Sep; 83():83-91. PubMed ID: 28720530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 2A as a potential target for anticancer therapy.
    Kalev P; Sablina AA
    Anticancer Agents Med Chem; 2011 Jan; 11(1):38-46. PubMed ID: 21288198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.
    Grech G; Baldacchino S; Saliba C; Grixti MP; Gauci R; Petroni V; Fenech AG; Scerri C
    Tumour Biol; 2016 Sep; 37(9):11691-11700. PubMed ID: 27444275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1.
    Bengtsson L; Schwappacher R; Roth M; Boergermann JH; Hassel S; Knaus P
    J Cell Sci; 2009 Apr; 122(Pt 8):1248-57. PubMed ID: 19339557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, regulation, and pharmacological modulation of PP2A phosphatases.
    Lambrecht C; Haesen D; Sents W; Ivanova E; Janssens V
    Methods Mol Biol; 2013; 1053():283-305. PubMed ID: 23860660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway.
    McConnell JL; Gomez RJ; McCorvey LR; Law BK; Wadzinski BE
    Oncogene; 2007 Sep; 26(41):6021-30. PubMed ID: 17384681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PP2A-B55 Holoenzyme Regulation and Cancer.
    Goguet-Rubio P; Amin P; Awal S; Vigneron S; Charrasse S; Mechali F; Labbé JC; Lorca T; Castro A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33266510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphatase 2A: a target for anticancer therapy.
    Perrotti D; Neviani P
    Lancet Oncol; 2013 May; 14(6):e229-38. PubMed ID: 23639323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein phosphatase 2A regulatory subunits and cancer.
    Eichhorn PJ; Creyghton MP; Bernards R
    Biochim Biophys Acta; 2009 Jan; 1795(1):1-15. PubMed ID: 18588945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells.
    Janssens V; Rebollo A
    Curr Mol Med; 2012 Mar; 12(3):268-87. PubMed ID: 22300139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.